March 2022

Study: DOACs Comparable With Warfarin in Cerebral Venous Thrombosis
In a retrospective study, researchers indicated that the use of direct oral anticoagulant drugs (DOACs) appears to be just as effective as warfarin in preventing future thrombotic events in patients with cerebral venous thrombosis (CVT) stroke and are less likely to cause major bleeding. Learn more about DOACs as an alternative approach to warfarin as a treatment for CVT.


Meta-Analysis Explores Prevalence of Statin Intolerance
A recent meta-analysis published online in the European Heart Journal involving over 4 million patients was conducted to obtain more information regarding the estimates of the actual prevalence of statin intolerance (SI), the prevalence according to different diagnostic criteria and in different disease settings, and to identify possible risk factors/conditions that might boost the risk of SI. Read more.

Debating CCBs Versus Other Antihypertensive Drug Classes
While calcium channel blockers (CCBs) are often recommended as a first-line drug to treat hypertension, the effect of CCBs on the prevention of cardiovascular events—compared with other antihypertensive drug classes—is still debated. A recent meta-analysis aimed to ascertain if the incidence of major adverse cardiovascular events was diminished if CCBs were used as first-line therapy for hypertension versus other antihypertension medications. Read more.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App